STAT proteins: novel molecular targets for cancer drug discovery.
about
STAT3 protein up-regulates Gα-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasisErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cellsIL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesisMesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistIdentification of a PTEN-regulated STAT3 brain tumor suppressor pathwayTargeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseTargeting the tumor microenvironment: JAK-STAT3 signalingTargeting apoptosis pathways in cancer with alantolactone and isoalantolactonePlant sterols as anticancer nutrients: evidence for their role in breast cancerMolecular aspects of development and regulation of endometriosisSTAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyCucurbitacins - An insight into medicinal leads from natureTip60 is a co-repressor for STAT3PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesisChemical probes that competitively and selectively inhibit Stat3 activationNecdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancerAnticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approachesIdentification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validationSTAT3 deletion sensitizes cells to oxidative stressPhosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformationMetabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancerA novel role for signal transducer and activator of transcription 5b (STAT5b) in beta1-integrin-mediated human breast cancer cell migration.A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.Muscadine grape skin extract reverts snail-mediated epithelial mesenchymal transition via superoxide species in human prostate cancer cells.Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity.Characterization of STAT3 activation and expression in canine and human osteosarcoma.Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiationOleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathwayPreclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapyStat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells.Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells.A cell-permeable Stat3 SH2 domain mimetic inhibits Stat3 activation and induces antitumor cell effects in vitro.Therapeutic modulators of STAT signalling for human diseasesTargeted disruption of stat3 reveals a major role for follicular stem cells in skin tumor initiation.Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activationRepositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
P2860
Q24300906-7912FD5A-26AF-4171-9C30-A31FE3C8DBE5Q24316918-9E2C1F27-F1A6-487B-AD0E-99EA87CBAEF9Q24604346-C80E3FA7-DB65-4CD8-8C85-528AF7C0887AQ24622968-4B2329AF-ECDE-4D3E-BCD6-03487A76CC9BQ24623979-B33C0350-EBA0-4549-B78F-4989407DEAF7Q24650927-4CE58358-DB60-4D43-A321-E46199D68B2EQ26750725-94D86B3E-BBCC-44BB-8BD5-5C4BC2DA66F5Q26825658-F66ADDEC-DA58-4DD3-AF8B-BFF9A0B010BAQ26850232-4A80E655-AA73-4139-BB1A-1F9AC2860C51Q26861053-27573C71-7491-4AE5-94F0-6904AEF159C4Q26865356-5E92570A-8630-4AF0-B7AF-B74EB6C43B69Q27003190-FF7DB3EE-E70D-4C57-BFAC-EC361118A1ACQ28082425-411C1A87-54C7-4C44-B4B6-A302681C39F2Q28205252-AC8BB132-19FC-4CEE-916E-BD88674F9BECQ28302461-748A58A0-F761-43B9-B189-5FF86ED8FB04Q28475010-B93A9E7C-7FD2-4806-B95F-C27B8B43178CQ28477663-5019A47B-BF70-45A4-A93C-D46D04407FB5Q28540187-F01405B4-AD76-4694-AA2A-45C834337E5CQ28543632-91215FD3-1006-4B99-9590-8154A0E03A1DQ28576805-C9AACA9C-81B4-4BAD-BE88-790BB2463EBBQ28593921-1283E669-F88F-492C-BC6F-C5E786F43B11Q28609305-048800B7-3AEC-470C-AAC8-90334CA49BBDQ30438451-47B824F3-5284-4B51-B38C-B49CD6E825FFQ30492764-F74ED8A9-B006-4E7A-AF5E-E47016B1B1D4Q31153800-E950C526-6137-4D3B-9F23-12BBFDB3FDADQ33282964-363410EC-6DCA-4F71-9CC9-ECE19E84E08FQ33417870-64C384E2-EB21-43F9-90CA-B3167F04DFD7Q33563809-A9901A8B-5D16-489E-84B9-FB4A97CCA164Q33565458-A51C525D-C864-497B-8934-2CF0C8FD341BQ33575279-0732EC7C-F891-4CAE-8B69-EF8DEA77A703Q33603599-DEAD26B3-AEBA-49B9-AA4D-CE174360FF21Q33649606-7E43E321-8E13-4172-9DBA-E2C60176BD70Q33658135-A2845BD2-CE45-4C11-B4E9-3C1FE7BB44F8Q33679564-1BC1232D-CFAC-4AEC-969A-751BB7DF4237Q33684732-EC481FFD-AE71-429E-A3DF-73B1D0392441Q33705396-A1F88CCE-3935-4A8E-9F9A-DA44BC485B4FQ33770989-1808DE98-BBA3-47E3-AD83-B6FFA46999D9Q33779633-D809B097-14A1-4BF2-BD9D-D9DC595E4F74Q33816368-149485EF-6179-4A39-B7D2-6392903C1644Q33866426-46A06D90-62A8-4BCF-9584-903027095002
P2860
STAT proteins: novel molecular targets for cancer drug discovery.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
STAT proteins: novel molecular targets for cancer drug discovery.
@ast
STAT proteins: novel molecular targets for cancer drug discovery.
@en
STAT proteins: novel molecular targets for cancer drug discovery.
@nl
type
label
STAT proteins: novel molecular targets for cancer drug discovery.
@ast
STAT proteins: novel molecular targets for cancer drug discovery.
@en
STAT proteins: novel molecular targets for cancer drug discovery.
@nl
prefLabel
STAT proteins: novel molecular targets for cancer drug discovery.
@ast
STAT proteins: novel molecular targets for cancer drug discovery.
@en
STAT proteins: novel molecular targets for cancer drug discovery.
@nl
P2860
P921
P356
P1433
P1476
STAT proteins: novel molecular targets for cancer drug discovery.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204086
P407
P577
2000-12-01T00:00:00Z
P5875
P6179
1015007460